ALK increases sales in Q2, but operating result decreases

Wednesday morning, allergy company ALK presented the full report for the year's second quarter. The central figures were known ahead of time, since the company upgraded its guidance on Monday.
Photo: ALK / PR
Photo: ALK / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN

Wednesday morning, pharmaceutical company ALK shed light on the last unknown figures in the company's Q2 report. Since the firm published the main figures for the quarter on Monday, there were no great surprises.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading